Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Finance Watch: Hua Medicine Raises $117.4m While Evaluating A Hong Kong IPO

Executive Summary

Hua, already considering an IPO in Hong Kong for up to $400m, closed concurrent VC rounds that will fund its late-stage diabetes program in China, but it may still need to go public to enter other markets. Also, Heron raised cash for its next commercial product, among other public company financings.

Advertisement

Related Content

Finance Watch: Global Ventures Step Into The Spotlight As The US Takes A Breather
Finance Watch: Is The IPO Boom Making Anyone Nervous Yet?
China Roundup: Innovent I/O Setback, Adagene, Hua Bag Millions, WuXi Relisting
From Inception, Tempest Plans To Kick Up IO Storm
Pipeline Watch: Phase III Progress With Eylea, Tecentriq And HTX-011
Pipeline Watch: Phase III Progress With Avelumab, Ixekizumab And Eravacycline
Pipeline Watch: Kisqali, SI-6603, Cosentyx Phase III Readouts
Incyte Adds PD-1 Inhibitor To Its Promising IDO With MacroGenics Deal
Duchenne Muscular Dystrophy: The Race For The $1bn Opportunity
Battle Lines Drawn In New Renal Anemia Market

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC100666

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel